Sarolaner/Moxidectin/Pyrantel
42 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
42
Total Reports
2
Deaths Reported
480.0%
Death Rate
Active Ingredients
Sarolaner/Moxidectin/Pyrantel
Administration Routes
OralUnknown
Species Affected
Dog 42
Most Affected Breeds
Retriever - Labrador 10
Shepherd Dog - German 3
Terrier (unspecified) 3
Dog (unknown) 2
Retriever - Golden 2
Beagle 2
Greyhound 2
Pit Bull 2
Siberian Husky 2
Bulldog 1
Most Reported Reactions
Vomiting 9
Lack of efficacy (endoparasite) - heartworm 5
Urinary incontinence 5
Lethargy (see also Central nervous system depression in Neurological) 5
Underdose 4
Overdose 4
Elevated alanine aminotransferase (ALT) 4
Panting 4
Other abnormal test result NOS 3
Seizure NOS 3
Diarrhoea 3
Lack of efficacy (endoparasite) - tapeworm 3
Outcome Breakdown
Outcome Unknown
22 (52.4%)
Recovered/Normal
13 (31.0%)
Ongoing
5 (11.9%)
Died
1 (2.4%)
Euthanized
1 (2.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.